Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.50 |
| ▸ | AHR | P35869 | 3/20 | 0.50 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | FYN | P06241 | 1/20 | 0.50 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20127332 | 0.97 | ABCG2 (0.48) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL19080015 | 0.93 | ABCG2 (0.47) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL19079932 | 0.92 | ABCG2 (0.49) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL20127337 | 0.91 | ABCG2 (0.46) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL22680424 | 0.91 | ABCG2 (0.46) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL31010716 | 0.91 | ABCG2 (0.46) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL20127335 | 0.91 | ABCG2 (0.48) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL20127737 | 0.91 | ABCG2 (0.48) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL20127739 | 0.90 | ABCG2 (0.45) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL22547234 | 0.88 | ABCG2 (0.46) | ABCG2AHRPAX8CYP1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230021165-A1 | COMPOSITION, DEPOSITION SOURCE, ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING SAME, AND MANUFACTURING METHOD THEREFOR | LG CHEM, LTD. (KR) | 2023-01-19 | — | — | US | disclosed |
| US-20210351358-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2021-11-11 | — | — | US | disclosed |
| US-20180208836-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| WO-2018128470-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | 머티어리얼사이언스 주식회사 | 2018-07-12 | — | — | WO | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | RER1, NR0B1, NR2E1 | ABCG2 3284/4885AHR 2558/4885PAX8 1540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.